Home › Research › Getting a diagnosis
Role of Artificial Intelligence in the Diagnosis of Dementia in the Elderly
Anirudh Joshi, Anirudh Joshi, Dr. Hanumanthachar Joshi, Sandhya P. International Journal of Community Pharmacy, 2025-09-30
Topic: Risk, prevention and care in population studies
Plain-language summary
Dementia, a progressive neurodegenerative disorder affecting memory, cognition, and behaviour, poses a major global health challenge in aging populations. The complexity of early diagnosis and the subtle onset of symptoms often delay intervention. In recent years, artificial intelligence (AI) has emerged as a transformative tool for the early detection, classification, and monitoring of dementia, particularly Alzheimer’s disease. AI-driven models leveraging neuroimaging, clinical data, speech analysis, and digital biomarkers are redefining diagnostic accuracy and efficiency. This review highlights the current advancements, methodologies, and challenges in the application of AI for dementia diagnosis in the elderly, and discusses its implications for clinical practice and future research.
What this study adds
Evidence grade: Low
This review discusses how artificial intelligence using neuroimaging, clinical data, speech analysis, and digital biomarkers may improve early detection and classification of dementia. It is a review of diagnostic approaches and does not report any treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Joshi, A., Joshi, D. H., & Sandhya, P. (2025). Role of Artificial Intelligence in the Diagnosis of Dementia in the Elderly. International Journal of Community Pharmacy. https://doi.org/10.65301/ijcp.2025.6.3.8
Vancouver
Joshi A, Joshi DH, Sandhya P. Role of Artificial Intelligence in the Diagnosis of Dementia in the Elderly. International Journal of Community Pharmacy. 2025. doi:10.65301/ijcp.2025.6.3.8.
BibTeX
@article{joshi2025-a0dc2da0,
author = {Joshi, Anirudh and Joshi, Dr. Hanumanthachar and Sandhya, P.},
title = {{Role of Artificial Intelligence in the Diagnosis of Dementia in the Elderly}},
journal = {International Journal of Community Pharmacy},
year = {2025},
doi = {10.65301/ijcp.2025.6.3.8},
url = {https://doi.org/10.65301/ijcp.2025.6.3.8}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Dementia, a progressive neurodegenerative disorder affecting memory, cognition, and behaviour, poses a major global health challenge in aging populations.
- The complexity of early diagnosis and the subtle onset of symptoms often delay intervention.
- In recent years, artificial intelligence (AI) has emerged as a transformative tool for the early detection, classification, and monitoring of dementia, particularly Alzheimer’s disease.
- AI-driven models leveraging neuroimaging, clinical data, speech analysis, and digital biomarkers are redefining diagnostic accuracy and efficiency.
- This review highlights the current advancements, methodologies, and challenges in the application of AI for dementia diagnosis in the elderly, and discusses its implications for clinical practice and future research.
Why it matters
This review discusses how artificial intelligence using neuroimaging, clinical data, speech analysis, and digital biomarkers may improve early detection and classification of dementia. It is a review of diagnostic approaches and does not report any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Evidence strengthLow
How this study scored 29/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 28 of the 96 points we could judge it on, which is 29 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International Journal of Community Pharmacy) |
| Journal's citation record | 0 / 4 | International Journal of Community Pharmacy: journal h-index 1 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Sandhya P holds only 3 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Indian Institute of Science Bangalore: institution h-index 466 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Points | 28 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 28 of the 96 points we could judge it on is 29 out of 100. |
| Total | 29 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.65301/ijcp.2025.6.3.8
- Original source →
- Free full text: International Journal of Community Pharmacy →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Getting a diagnosis from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.